[1]
Chou KC. An insightful 10-year recollection since the emergence of the 5-steps rule. Curr Pharm Des 2019; 25(40): 4223-34.
[2]
Dong Y, Qu X, Wu G, et al. Advances in the detection, mechanism and therapy studies of chronic kidney disease. Curr Pharm Des 2019; 25(40): 4235-50.
[3]
Zhang Y, Liu Z. Oncolytic virotherapy for malignant tumor: current clinical status. Curr Pharm Des 2019; 25(40): 4251-63.
[4]
Zhou G, Zhao M, Liang R, et al. Study of mechanism on binding between neratinib and MAD2L1 based on molecule simulation and multi-spectroscopy methods. Curr Pharm Des 2019; 25(40): 4287-95.
[5]
Zhang D, Guan Z-X, Zhang Z-M, et al. Recent development of computational predicting bioluminescent proteins. Curr Pharm Des 2019; 25(40): 4264-73.
Current Pharmaceutical Design
Title:Advancement of Technology for Precision Medicine
Volume: 25 Issue: 40
Author(s): Bing Niu
Affiliation:
Export Options
About this article
Cite this article as:
Niu Bing , Advancement of Technology for Precision Medicine, Current Pharmaceutical Design 2019; 25 (40) . https://dx.doi.org/10.2174/138161282540191230093056
DOI https://dx.doi.org/10.2174/138161282540191230093056 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
11
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Alternative Splicing: A Promising Target for Pharmaceutical Inhibition of Pathological Angiogenesis?
Current Pharmaceutical Design Cytochrome P450 Drug Metabolizing Enzymes in Roma Population Samples: Systematic Review of the Literature
Current Medicinal Chemistry MicroRNA-34a Promotes Cardiomyocyte Apoptosis Post Myocardial Infarction Through Down-regulating Aldehyde Dehydrogenase 2
Current Pharmaceutical Design Targeted Therapies in Lung Cancer
Current Pharmaceutical Design Targets for Anti-metastatic Drug Development
Current Pharmaceutical Design Histone Deacetylase Inhibitor Trichostatin A Suppresses Cell Proliferation and Induces Apoptosis by Regulating the PI3K/AKT Signalling Pathway in Gastric Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Immune Checkpoint Regulators: A New Era Toward Promising Cancer Therapy
Current Cancer Drug Targets Hyaluronic Acid: Targeting Immune Modulatory Components of the Extracellular Matrix in Atherosclerosis
Current Medicinal Chemistry Preface
Current Protein & Peptide Science Nampt/Visfatin/PBEF: A Functionally Multi-faceted Protein with a Pivotal Role in Malignant Tumors
Current Pharmaceutical Design Synthesis, Characterization, Antimicrobial and Antitumor Activities of Sucrose Octa(N-ethyl)carbamate
Medicinal Chemistry Mikuliczs Disease and its Extraglandular Lesions
Current Immunology Reviews (Discontinued) Drug Metabolism and Pharmacokinetics of Dammarane Triterpenoids
Current Drug Metabolism A Facile “Click Chemistry” Approach to Novel Flavonol Glycoconjugates and Their Cytotoxic Activity
Letters in Organic Chemistry Advancement and Strategies for the Development of Peptide-drug Conjugates: Pharmacokinetic Modulation, Role and Clinical Evidence against Cancer Management
Current Cancer Drug Targets Immunological Mechanism and Clinical Application of PAMP Adjuvants
Recent Patents on Anti-Cancer Drug Discovery Experience with Indium-111 and Yttrium-90-Labeled Somatostatin Analogs
Current Pharmaceutical Design Adenoviral Vectors for Cancer Gene Therapy
Current Genomics Metal Containing Cytostatics and Their Interaction with Cellular Thiol Compounds Causing Chemoresistance
Anti-Cancer Agents in Medicinal Chemistry Antioxidant and Cytotoxicity Activity of Phenolic Compounds from Piper sarmentosum Roxb. Against T47D Human Breast Cancer Cell
The Natural Products Journal